Paper33423701
Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA.
El-Mais N and 4 others. J Ovarian Res, 2021. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA. Papers, record 33423701. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33423701
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arginase | Major topic |
| Arginine | Major topic |
| Ovarian Neoplasms | Major topic |
| rhoA GTP-Binding Protein | Major topic |
| Autophagy | |
| Cell Adhesion | |
| Cell Line, Tumor | |
| Cell Movement | |
| Cell Proliferation | |
| Female | |
| Humans | |
| Transfection |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA100324 | NCI NIH HHS | United States | P01CA100324 | PubMed | NIH RePORTER |
| U54 GM064346 | NIGMS NIH HHS | United States | U54GM064346 | PubMed | NIH RePORTER |
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15569838 | Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. | Circulation | 2004 | https://conductscience.org/library/papers/15569838 | PubMed |
| 2 | 31795337 | Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31795337 | PubMed |
| 3 | 24253896 | Effect of StarD13 on colorectal cancer proliferation, motility and invasion. | Oncol Rep | 2014 | https://conductscience.org/library/papers/24253896 | PubMed |
| 4 | 27184837 | Autophagy Promotes Focal Adhesion Disassembly and Cell Motility of Metastatic Tumor Cells through the Direct Interaction of Paxillin with LC3. | Cell Rep | 2016 | https://conductscience.org/library/papers/27184837 | PubMed |
| 5 | 30887252 | Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent. | Invest New Drugs | 2020 | https://conductscience.org/library/papers/30887252 | PubMed |
| 6 | 25567351 | Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. | J Neurooncol | 2015 | https://conductscience.org/library/papers/25567351 | PubMed |
| 7 | 19575647 | Mechanical integration of actin and adhesion dynamics in cell migration. | Annu Rev Cell Dev Biol | 2010 | https://conductscience.org/library/papers/19575647 | PubMed |
| 8 | 20729930 | Cell adhesion: integrating cytoskeletal dynamics and cellular tension. | Nat Rev Mol Cell Biol | 2010 | https://conductscience.org/library/papers/20729930 | PubMed |
| 9 | 26150935 | Step-by-step quantitative analysis of focal adhesions. | MethodsX | 2014 | https://conductscience.org/library/papers/26150935 | PubMed |
| 10 | 31823161 | [HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells. | Invest New Drugs | 2020 | https://conductscience.org/library/papers/31823161 | PubMed |
| 11 | 27120804 | Autophagy suppresses cell migration by degrading GEF-H1, a RhoA GEF. | Oncotarget | 2016 | https://conductscience.org/library/papers/27120804 | PubMed |
| 12 | 31698752 | Hypoxia and EGF Stimulation Regulate VEGF Expression in Human Glioblastoma Multiforme (GBM) Cells by Differential Regulation of the PI3K/Rho-GTPase and MAPK Pathways. | Cells | 2019 | https://conductscience.org/library/papers/31698752 | PubMed |
| 13 | 24930891 | Invadopodia, regulation, and assembly in cancer cell invasion. | Cell Commun Adhes | 2014 | https://conductscience.org/library/papers/24930891 | PubMed |
| 14 | 20104527 | Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. | Int J Cancer | 2010 | https://conductscience.org/library/papers/20104527 | PubMed |
| 15 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 16 | 31368405 | Nanoparticle-siRNA: a potential strategy for ovarian cancer therapy? | Nanomedicine (Lond) | 2019 | https://conductscience.org/library/papers/31368405 | PubMed |
| 17 | 24333506 | The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility. | Exp Cell Res | 2014 | https://conductscience.org/library/papers/24333506 | PubMed |
| 18 | 24627003 | StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion. | Int J Oncol | 2014 | https://conductscience.org/library/papers/24627003 | PubMed |
| 19 | 10698528 | Motility and invasion are differentially modulated by Rho family GTPases. | Oncogene | 2000 | https://conductscience.org/library/papers/10698528 | PubMed |
| 20 | 12478284 | Rho GTPases in cell biology. | Nature | 2002 | https://conductscience.org/library/papers/12478284 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42649936 | Overcoming Therapy Resistance in Ovarian Cancer: From Molecular Mechanisms to Emerging Therapeutic Strategies. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649936 | PubMed |
| 41814059 | Artificial intelligence-assisted spatial omics-based biomimetic nanoplatform for intelligent and precise intervention in the immunosuppressive core region of ovarian cancer. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/41814059 | PubMed |
| 39676338 | Exploring Metabolic Approaches for Epithelial Ovarian Cancer Therapy. | J Cell Physiol | 2025 | https://conductscience.org/library/papers/39676338 | PubMed |
| 38326899 | Selective enhanced cytotoxicity of amino acid deprivation for cancer therapy using thermozyme functionalized nanocatalyst. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/38326899 | PubMed |
| 38247807 | Modulation of Cisplatin Sensitivity through TRPML1-Mediated Lysosomal Exocytosis in Ovarian Cancer Cells: A Comprehensive Metabolomic Approach. | Cells | 2024 | https://conductscience.org/library/papers/38247807 | PubMed |
| 37445845 | Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37445845 | PubMed |
| 36328835 | Plasticity of cancer invasion and energy metabolism. | Trends Cell Biol | 2023 | https://conductscience.org/library/papers/36328835 | PubMed |
| 36311734 | Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy. | Front Immunol | 2022 | https://conductscience.org/library/papers/36311734 | PubMed |
| 36131790 | SLC7A1 Overexpression Is Involved in Energy Metabolism Reprogramming to Induce Tumor Progression in Epithelial Ovarian Cancer and Is Associated with Immune-Infiltrating Cells. | J Oncol | 2022 | https://conductscience.org/library/papers/36131790 | PubMed |
| 35771627 | Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives. | Cancer Res | 2022 | https://conductscience.org/library/papers/35771627 | PubMed |
| 34309734 | Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment. | Cancer Chemother Pharmacol | 2021 | https://conductscience.org/library/papers/34309734 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ASS1 | 445 | PubTator's text mining | https://conductscience.org/library/genes/445 | NCBI Gene |
| CDC42 | 998 | PubTator's text mining | https://conductscience.org/library/genes/998 | NCBI Gene |
| MAP1LC3A | 84557 | PubTator's text mining | https://conductscience.org/library/genes/84557 | NCBI Gene |
| MAP1LC3B | 81631 | PubTator's text mining | https://conductscience.org/library/genes/81631 | NCBI Gene |
| MTG1 | 92170 | PubTator's text mining | https://conductscience.org/library/genes/92170 | NCBI Gene |
| POTEF | 728378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
| RAC1 | 5879 | PubTator's text mining | https://conductscience.org/library/genes/5879 | NCBI Gene |
| RHO | 6010 | PubTator's text mining | https://conductscience.org/library/genes/6010 | NCBI Gene |
| RHOA | 387 | PubTator's text mining | https://conductscience.org/library/genes/387 | NCBI Gene |
| VCL | 7414 | PubTator's text mining | https://conductscience.org/library/genes/7414 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33423701
GET https://conductscience.org/api/papers/v1/33423701/references?page=2